Valeant acquires Bausch Lomb in 8.7 billion cash deal
Valeant Pharmaceuticals International Inc. has acquired global eye health company Bausch & Lomb Holdings, whose pharmaceutical headquarters are based in Madison, for $8.7 billion in cash.
Coordinated-care effort likely to win backing from state’s biggest insurers
New Jersey will soon launch a Medicaid accountable-care organization pilot that will demonstrate whether getting doctors, hospitals and other professionals working together can both improve patient health and rein in millions of dollars in avoidable hospital admissions and emergency room visits.
New payment model is something Viocare can sink its teeth into
The dietary behavior research firm Viocare makes an online tool that enables health care providers like the Mayo Clinic to gather 90 days of dietary data from a patient in just 30 minutes — then use this knowledge to help the patient adopt a healthier lifestyle.
Leaderboard Growing to meet challenges of changing care models
Employee benefits consultant Benefit Sources & Solutions Chadler has spent years developing the expertise to guide employers through the 2010 Affordable Care Act, which next year will levy fines on employers with more than 50 full-time workers that don't offer a health plan.
New CEO named at Cooper University Health Care in Camden
The Cooper Health System Board of Trustees has named Adrienne Kirby president and chief executive officer of Cooper University Health Care.
Mylan marks 25th anniversary of landmark EpiPen
Mylan Specialty has begun offering EpiPen, the landmark autoinjector that treats severe allegoric reactions, with no co-pay to mark the 25th anniversary of the product’s approval by the Food and Drug Administration.
Health centers get 3.3M to help enroll uninsured
New Jersey's 20 federally funded health centers, which treat thousands of low-income patients without health coverage, can now apply for $3.3 million in new federal funds to hire and train staff to enroll the uninsured in government-subsidized health insurance and Medicaid under the Affordable Care Act.
Better diagnosis will save lives, boost company profit
Cancer Genetics CEO Panna Sharma pins his hopes on the conviction that better diagnosis of cancer will extend lives and save money. It follows that investors would reward such diagnostics companies, he said.
Senesco announced 1.25 million equity financing
Senesco Technologies Inc., of Bridgewater, announced Thursday it has entered into a securities purchase agreement with institutional investors to raise $1.25 million in gross proceeds through the sale of 41.8 million shares of its common stock, priced at 3 cents per share.
Pharma, testing companies announce partnership
Arno Therapeutics Inc., a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today announced it has signed an agreement with Clarient Diagnostic Services Inc., a GE Healthcare subsidiary, to develop a diagnostic test to identify activated progesterone receptors in endometrial cancer.
Medicaid expansion clears committee
The Senate Health, Human Services and Senior Citizens Committee Tuesday voted to release S-2644, a bill to expand Medicaid eligibility in the state to residents earning up to 133 percent of the federal poverty line. The federal government will pick up the cost of that expansion for three years, and 90 percent of the costs the following three years.
Paving the way for a reopening at shuttered hospital in Pascack Valley
A new Bergen County hospital that opens June 1 will be both the clinical and financial offspring of its joint-venture parents — Hackensack University Medical Center and the for-profit LHP Hospital Group — executives from both institutions promised last week during a tour of the $148 million facility that replaces the former Pascack...